NCT00470912|CompletedPhase 3
Sunscreen RV 2457C in Photoinduced CLE
Photoprotective Effects of the RV 2457C Sunscreen Milk in Photoinduced Cutaneous Lupus Erythematosus
Loading search results
Photoprotective Effects of the RV 2457C Sunscreen Milk in Photoinduced Cutaneous Lupus Erythematosus
Sponsor study identifier
interventional
25
1 country
1
Study Start
May 2001
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
February 2002
Actual (reported)Lupus erythematosus (LE) is characterized by a large clinical spectrum, and sunligt is a well established factor in the induction and exacerbation of this disease. In all subsets of LE, skin lesions occur preferentially in sun-exposed areas. Previous studies have demonstrated that the lesions in LE patients reproduced in controlled experimental conditions. The initial reports suggested that the action spectrum for the LE was in the UVB range (290 to 320 nm), but more recent studies have demonstrated that UVA (320 to 400 nm) can contribute to the induction of LE skin lesions. Antimalarial agents and topical steroids are the main treatments of chronic LE. The second line therapies include retinoids, sulfones, immunosuppressor agents, systemic corticosteroid and thalidomide. Moreover, patients are advised to avoid sun, to wear sunprotective clothing and to apply sunscreen. The aim of this study was to assess the efficacy of a sunscreen milk with high protection factor against UV-B and UV-A, used exclusively, in the photoinduced LE.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2002
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2001
Date type not reportedThis date has not been verified as actual or estimated.
February 2002
Actual (reported)May 7, 2007
Actual (reported)May 8, 2007
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Heinrich Heine University of Duesseldorf, Depatment of Dermatoly
Düsseldorf, North Rhine-Westphalia, 40225, Germany
Annegret Kuhn, MD
Heinrich-Heine University of Duesseldorf, Department of Dermatolgy
25 participants (actual enrollment reported by the registry).
First Submitted
May 7, 2007
First Posted
May 8, 2007
Study Start
May 2001
Date type not reportedThis date has not been verified as actual or estimated.
Contact the study team to confirm eligibility.
Study Completion
February 2002
Actual (reported)Last Updated
May 8, 2007
Record last verified: 2007-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: